| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.481 | 0.013 | 0.481 | Psychostimulant | 0.34 0.033 DBMET01548 0.41 0.021 DBMET01549 0.41 0.021 DBMET01550 | ||
| 0.427 | 0.003 | 0.427 | HIV-1 protease inhibitor | 0.304 0.003 DBMET01548 0.364 0.003 DBMET01549 0.364 0.003 DBMET01550 | ||
| 0.402 | 0.004 | 0.402 | Protease inhibitor | 0.341 0.005 DBMET01548 0.364 0.004 DBMET01549 0.364 0.004 DBMET01550 | ||
| 0.422 | 0.028 | 0.422 | Interleukin antagonist | 0.388 0.033 DBMET01548 0.409 0.029 DBMET01549 0.409 0.029 DBMET01550 | ||
| 0.315 | 0.004 | 0.315 | Human rhinovirus A protease inhibitor | 0.285 0.004 DBMET01548 0.288 0.004 DBMET01549 0.288 0.004 DBMET01550 | ||
| 0.269 | 0.013 | 0.269 | Proteasome inhibitor | 0.221 0.02 DBMET01548 0.233 0.018 DBMET01549 0.233 0.018 DBMET01550 | ||
| 0.312 | 0.069 | 0.343 | Nootropic | 0.343 0.056 DBMET01548 0.273 0.09 DBMET01549 0.273 0.09 DBMET01550 | DBMET01548 | |
| 0.258 | 0.041 | 0.283 | Growth hormone agonist | 0.25 0.043 DBMET01548 0.283 0.036 DBMET01549 0.283 0.036 DBMET01550 | DBMET01550 | |
| 0.271 | 0.062 | 0.271 | Antiamyloidogenic | 0.154 0.142 DBMET01548 0.213 0.091 DBMET01549 0.213 0.091 DBMET01550 | ||
| 0.294 | 0.089 | 0.335 | Apoptosis antagonist | 0.266 0.112 DBMET01548 0.335 0.063 DBMET01549 0.335 0.063 DBMET01550 | DBMET01550 | |
| 0.227 | 0.026 | 0.233 | Nav1.2 sodium channel blocker | 0.233 0.025 DBMET01548 0.148 0.058 DBMET01549 0.148 0.058 DBMET01550 | DBMET01548 | |
| 0.257 | 0.09 | 0.257 | Ca(v)3.3 blocker | 0.203 0.185 DBMET01548 0.227 0.139 DBMET01549 0.227 0.139 DBMET01550 | ||
| 0.207 | 0.049 | 0.212 | Thrombolytic | 0.193 0.055 DBMET01548 0.212 0.046 DBMET01549 0.212 0.046 DBMET01550 | DBMET01550 | |
| 0.192 | 0.039 | 0.192 | Neurotensin receptor agonist | 0.164 0.071 DBMET01548 0.143 0.119 DBMET01549 0.143 0.119 DBMET01550 | ||
| 0.258 | 0.109 | 0.307 | Immunomodulator | 0.294 0.086 DBMET01548 0.307 0.078 DBMET01549 0.307 0.078 DBMET01550 | DBMET01550 | |
| 0.185 | 0.046 | 0.185 | Catenin beta inhibitor | 0.178 0.054 DBMET01548 0.164 0.076 DBMET01549 0.164 0.076 DBMET01550 | ||
| 0.187 | 0.058 | 0.187 | Anticoagulant | 0.159 0.073 DBMET01548 0.169 0.067 DBMET01549 0.169 0.067 DBMET01550 | ||
| 0.226 | 0.098 | 0.294 | Cardiotonic | 0.187 0.132 DBMET01548 0.294 0.059 DBMET01549 0.294 0.059 DBMET01550 | DBMET01550 | |
| 0.143 | 0.015 | 0.143 | Neuropeptide agonist | 0.14 0.016 DBMET01548 0.132 0.019 DBMET01549 0.132 0.019 DBMET01550 | ||
| 0.213 | 0.088 | 0.261 | Angiogenesis stimulant | 0.223 0.083 DBMET01548 0.261 0.065 DBMET01549 0.261 0.065 DBMET01550 | DBMET01550 | |
| 0.248 | 0.128 | 0.303 | Antithrombotic | 0.303 0.086 DBMET01549 0.303 0.086 DBMET01550 | DBMET01550 | |
| 0.206 | 0.092 | 0.277 | Peptidyltransferase inhibitor | 0.213 0.084 DBMET00387 0.277 0.034 DBMET01548 0.243 0.056 DBMET01549 0.243 0.056 DBMET01550 | DBMET01548 | |
| 0.242 | 0.128 | 0.293 | Interleukin 2 agonist | 0.244 0.126 DBMET01548 0.293 0.079 DBMET01549 0.293 0.079 DBMET01550 | DBMET01550 | |
| 0.128 | 0.016 | 0.128 | 3C-Like protease (SARS coronavirus) inhibitor | 0.118 0.02 DBMET01548 0.116 0.021 DBMET01549 0.116 0.021 DBMET01550 | ||
| 0.118 | 0.007 | 0.118 | Gonadotropin-releasing hormone receptor agonist | 0.118 0.007 DBMET01548 0.101 0.01 DBMET01549 0.101 0.01 DBMET01550 | ||
| 0.138 | 0.029 | 0.138 | Opioid antagonist | 0.123 0.035 DBMET01548 0.122 0.036 DBMET01549 0.122 0.036 DBMET01550 | ||
| 0.217 | 0.114 | 0.217 | Transcription factor STAT3 inhibitor | 0.198 0.137 DBMET01549 0.198 0.137 DBMET01550 | ||
| 0.167 | 0.063 | 0.21 | Diuretic | 0.21 0.041 DBMET01548 0.151 0.077 DBMET01549 0.151 0.077 DBMET01550 | DBMET01548 | |
| 0.116 | 0.014 | 0.116 | Cathepsin D inhibitor | 0.114 0.014 DBMET01548 0.103 0.018 DBMET01549 0.103 0.018 DBMET01550 | ||
| 0.121 | 0.022 | 0.121 | Hematopoietic | 0.117 0.023 DBMET01548 0.112 0.026 DBMET01549 0.112 0.026 DBMET01550 | ||
| 0.101 | 0.009 | 0.101 | Dipeptidyl peptidase inhibitor | 0.097 0.009 DBMET01548 0.061 0.024 DBMET01549 0.061 0.024 DBMET01550 | ||
| 0.13 | 0.044 | 0.13 | Nav1.4 sodium channel blocker | 0.122 0.05 DBMET01548 0.118 0.054 DBMET01549 0.118 0.054 DBMET01550 | ||
| 0.089 | 0.008 | 0.089 | HCV NS3/NS4A protease inhibitor | 0.063 0.018 DBMET01548 0.083 0.01 DBMET01549 0.083 0.01 DBMET01550 | ||
| 0.123 | 0.043 | 0.123 | Falcipain inhibitor | 0.103 0.052 DBMET01548 0.094 0.059 DBMET01549 0.094 0.059 DBMET01550 | ||
| 0.108 | 0.029 | 0.108 | Opioid mu receptor antagonist | 0.095 0.034 DBMET01548 0.093 0.034 DBMET01549 0.093 0.034 DBMET01550 | ||
| 0.1 | 0.022 | 0.1 | Glucagon-like peptide 1 agonist | 0.098 0.023 DBMET01548 0.093 0.026 DBMET01549 0.093 0.026 DBMET01550 | ||
| 0.083 | 0.005 | 0.083 | Plasmepsin II inhibitor | 0.063 0.01 DBMET01548 0.064 0.01 DBMET01549 0.064 0.01 DBMET01550 | ||
| 0.096 | 0.021 | 0.096 | Secretase beta inhibitor | 0.095 0.021 DBMET01548 0.071 0.047 DBMET01549 0.071 0.047 DBMET01550 | ||
| 0.205 | 0.131 | 0.205 | Transcription factor STAT inhibitor | 0.185 0.16 DBMET01549 0.185 0.16 DBMET01550 | ||
| 0.116 | 0.043 | 0.116 | Factor V inhibitor | 0.112 0.048 DBMET01548 0.111 0.049 DBMET01549 0.111 0.049 DBMET01550 | ||
| 0.099 | 0.03 | 0.099 | Opioid delta receptor antagonist | 0.083 0.035 DBMET01548 0.082 0.036 DBMET01549 0.082 0.036 DBMET01550 | ||
| 0.087 | 0.019 | 0.087 | Cathepsin E inhibitor | 0.081 0.022 DBMET01548 0.077 0.024 DBMET01549 0.077 0.024 DBMET01550 | ||
| 0.085 | 0.018 | 0.085 | Protease activated receptor 1 antagonist | 0.07 0.023 DBMET01548 0.073 0.021 DBMET01549 0.073 0.021 DBMET01550 | ||
| 0.141 | 0.079 | 0.141 | Hemostatic | 0.119 0.115 DBMET01548 0.133 0.091 DBMET01549 0.133 0.091 DBMET01550 | ||
| 0.081 | 0.025 | 0.081 | Bombesin 1 receptor agonist | 0.077 0.027 DBMET01548 0.068 0.033 DBMET01549 0.068 0.033 DBMET01550 | ||
| 0.12 | 0.065 | 0.124 | Cell adhesion inhibitor | 0.102 0.086 DBMET01548 0.124 0.062 DBMET01549 0.124 0.062 DBMET01550 | DBMET01550 | |
| 0.187 | 0.133 | 0.28 | Interleukin agonist | 0.28 0.059 DBMET01548 0.278 0.06 DBMET01549 0.278 0.06 DBMET01550 | DBMET01548 | |
| 0.111 | 0.06 | 0.111 | Falcipain 3 inhibitor | 0.089 0.082 DBMET01548 | ||
| 0.129 | 0.082 | 0.156 | Neurotrophic factor | 0.121 0.094 DBMET01548 0.156 0.054 DBMET01549 0.156 0.054 DBMET01550 | DBMET01550 | |
| 0.171 | 0.125 | 0.196 | Platelet antagonist | 0.196 0.104 DBMET01549 0.196 0.104 DBMET01550 | DBMET01550 | |
| 0.051 | 0.007 | 0.051 | Plasmepsin I inhibitor | 0.047 0.009 DBMET01548 0.046 0.009 DBMET01549 0.046 0.009 DBMET01550 | ||
| 0.07 | 0.032 | 0.07 | Caspase 9 inhibitor | 0.066 0.037 DBMET01548 0.069 0.033 DBMET01549 0.069 0.033 DBMET01550 | ||
| 0.085 | 0.048 | 0.085 | Chymotrypsin inhibitor | 0.081 0.053 DBMET01548 0.075 0.061 DBMET01549 0.075 0.061 DBMET01550 | ||
| 0.231 | 0.201 | 0.233 | Analgesic | 0.224 0.209 DBMET00387 0.233 0.199 DBMET01548 0.222 0.211 DBMET01549 0.222 0.211 DBMET01550 | DBMET01548 | |
| 0.169 | 0.14 | 0.267 | Immunostimulant | 0.195 0.123 DBMET01548 0.267 0.09 DBMET01549 0.267 0.09 DBMET01550 | DBMET01550 | |
| 0.061 | 0.032 | 0.061 | Bombesin 3 receptor antagonist | 0.054 0.041 DBMET01549 0.054 0.041 DBMET01550 | ||
| 0.048 | 0.02 | 0.048 | Melanocortin 1 antagonist | |||
| 0.04 | 0.013 | 0.04 | Dipeptidyl peptidase I inhibitor | 0.034 0.017 DBMET01548 0.034 0.017 DBMET01549 0.034 0.017 DBMET01550 | ||
| 0.077 | 0.051 | 0.077 | Analgesic, opioid | 0.074 0.056 DBMET01548 0.072 0.059 DBMET01549 0.072 0.059 DBMET01550 | ||
| 0.046 | 0.02 | 0.046 | Renin inhibitor | 0.043 0.021 DBMET01548 0.036 0.026 DBMET01549 0.036 0.026 DBMET01550 | ||
| 0.052 | 0.026 | 0.052 | Bombesin antagonist | 0.048 0.032 DBMET01548 0.049 0.031 DBMET01549 0.049 0.031 DBMET01550 | ||
| 0.115 | 0.09 | 0.119 | Bone formation stimulant | 0.113 0.092 DBMET01548 0.119 0.087 DBMET01549 0.119 0.087 DBMET01550 | DBMET01550 | |
| 0.193 | 0.168 | 0.193 | Insulysin inhibitor | |||
| 0.06 | 0.035 | 0.06 | Cathepsin B inhibitor | 0.055 0.041 DBMET01548 0.053 0.044 DBMET01549 0.053 0.044 DBMET01550 | ||
| 0.07 | 0.047 | 0.07 | Elastase 1 inhibitor | 0.066 0.053 DBMET01548 | ||
| 0.047 | 0.025 | 0.047 | Dipeptidyl peptidase IV inhibitor | 0.046 0.027 DBMET01548 | ||
| 0.048 | 0.026 | 0.048 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.032 DBMET01548 0.045 0.035 DBMET01549 0.045 0.035 DBMET01550 | ||
| 0.077 | 0.055 | 0.077 | Somatostatin 1 agonist | 0.07 0.064 DBMET01548 0.069 0.067 DBMET01549 0.069 0.067 DBMET01550 | ||
| 0.08 | 0.058 | 0.08 | Opioid kappa receptor antagonist | 0.072 0.071 DBMET01549 0.072 0.071 DBMET01550 | ||
| 0.056 | 0.035 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.053 0.041 DBMET01548 0.052 0.043 DBMET01549 0.052 0.043 DBMET01550 | ||
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | 0.047 0.039 DBMET01548 | ||
| 0.062 | 0.044 | 0.062 | Protease activated receptor antagonist | |||
| 0.029 | 0.01 | 0.029 | Aminopeptidase P inhibitor | 0.026 0.013 DBMET01548 0.025 0.014 DBMET01549 0.025 0.014 DBMET01550 | ||
| 0.082 | 0.063 | 0.082 | Factor XII inhibitor | 0.078 0.071 DBMET01548 | ||
| 0.032 | 0.013 | 0.032 | Vasopressin 1A agonist | 0.031 0.015 DBMET01548 0.03 0.016 DBMET01549 0.03 0.016 DBMET01550 | ||
| 0.037 | 0.019 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.022 DBMET01548 0.035 0.025 DBMET01549 0.035 0.025 DBMET01550 | ||
| 0.071 | 0.054 | 0.071 | Thrombin inhibitor | |||
| 0.053 | 0.037 | 0.053 | Opioid agonist | 0.048 0.042 DBMET01549 0.048 0.042 DBMET01550 | ||
| 0.047 | 0.033 | 0.047 | Melanocortin antagonist | |||
| 0.042 | 0.028 | 0.042 | Cholecystokinin antagonist | |||
| 0.032 | 0.019 | 0.032 | AMPA 2 receptor antagonist | |||
| 0.041 | 0.029 | 0.041 | Neurokinin 2 agonist | 0.04 0.03 DBMET01548 | ||
| 0.041 | 0.03 | 0.041 | Melanocortin 4 antagonist | |||
| 0.039 | 0.029 | 0.039 | Cathepsin L2 inhibitor | 0.035 0.032 DBMET01549 0.035 0.032 DBMET01550 | ||
| 0.165 | 0.155 | 0.165 | Calpain inhibitor | |||
| 0.044 | 0.035 | 0.044 | Endothelin-converting enzyme inhibitor | |||
| 0.031 | 0.022 | 0.031 | Caspase 2 inhibitor | 0.029 0.024 DBMET01548 0.028 0.025 DBMET01549 0.028 0.025 DBMET01550 | ||
| 0.022 | 0.014 | 0.022 | Human T-cell leukemia virus type I protease inhibitor | 0.019 0.017 DBMET01548 | ||
| 0.042 | 0.034 | 0.042 | Neurotensin receptor antagonist | |||
| 0.043 | 0.036 | 0.043 | Opioid mu receptor agonist | |||
| 0.032 | 0.025 | 0.032 | Growth hormone releasing factor agonist | 0.029 0.027 DBMET01548 | ||
| 0.022 | 0.016 | 0.031 | Follicle-stimulating hormone agonist | 0.031 0.01 DBMET01548 | DBMET01548 | |
| 0.035 | 0.03 | 0.035 | Cholecystokinin B agonist | 0.034 0.032 DBMET01548 | ||
| 0.201 | 0.196 | 0.342 | Immunosuppressant | 0.342 0.091 DBMET01548 0.279 0.128 DBMET01549 0.279 0.128 DBMET01550 | DBMET01548 | |
| 0.04 | 0.035 | 0.04 | Cathepsin F inhibitor | |||
| 0.033 | 0.029 | 0.033 | Cholecystokinin A antagonist | |||
| 0.034 | 0.03 | 0.034 | Bombesin 1 receptor antagonist | |||
| 0.026 | 0.023 | 0.027 | Bradykinin B2 receptor agonist | 0.027 0.022 DBMET01548 0.025 0.024 DBMET01549 0.025 0.024 DBMET01550 | DBMET01548 | |
| 0.02 | 0.019 | 0.02 | Vasopressin 1 agonist | |||
| 0.033 | 0.032 | 0.033 | Antidiuretic hormone antagonist | |||
| 0.037 | 0.036 | 0.037 | Growth hormone release inhibitor | |||
| 0.02 | 0.019 | 0.02 | Melanocortin 4 agonist | |||
| 0.028 | 0.029 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 DBMET01548 | DBMET01548 | |
| 0.084 | 0.092 | 0.087 | Nav1.1 sodium channel blocker | 0.087 0.086 DBMET00387 | DBMET00387 | |
| 0.131 | 0.148 | 0.153 | P-glycoprotein inhibitor | 0.153 0.112 DBMET01549 0.153 0.112 DBMET01550 | DBMET01550 | |
| 0.145 | 0.164 | 0.17 | Vasodilator | 0.17 0.131 DBMET01549 0.17 0.131 DBMET01550 | DBMET01550 | |
| 0.038 | 0.071 | 0.069 | Cannabinoid CB1 receptor agonist | 0.069 0.036 DBMET01548 | DBMET01548 | |
| 0.113 | 0.154 | 0.144 | Platelet adhesion inhibitor | 0.144 0.113 DBMET01549 0.144 0.113 DBMET01550 | DBMET01550 | |
| 0.117 | 0.203 | 0.167 | Spasmolytic | 0.167 0.147 DBMET00387 | DBMET00387 | |
| 0.165 | 0.253 | 0.207 | Antiobesity | 0.207 0.2 DBMET00387 | DBMET00387 | |
| 0.042 | 0.16 | 0.1 | Antiadrenergic | 0.1 0.056 DBMET00387 | DBMET00387 | |
| 0.04 | 0.159 | 0.097 | Adrenaline antagonist | 0.097 0.055 DBMET00387 | DBMET00387 | |
| 0.183 | 0.302 | 0.249 | Cyclophilin D inhibitor | 0.243 0.221 DBMET00387 0.241 0.224 DBMET01548 0.249 0.214 DBMET01549 0.249 0.214 DBMET01550 | DBMET01550 | |
| 0.025 | 0.202 | 0.063 | Factor IXa inhibitor | 0.063 0.024 DBMET00387 | DBMET00387 | |
| 0.036 | 0.246 | 0.084 | Bronchodilator | 0.084 0.081 DBMET00387 | DBMET00387 | |
| 0.005 | 0.22 | 0.05 | Sigma receptor antagonist | 0.05 0.034 DBMET00387 | DBMET00387 | |
| 0.039 | 0.292 | 0.107 | Acetylcholine antagonist | 0.107 0.083 DBMET00387 | DBMET00387 | |
| 0.147 | 0.402 | 0.41 | Calcium channel L-type activator | 0.41 0.074 DBMET00387 | DBMET00387 | |
| 0.039 | 0.298 | 0.108 | Cholinergic antagonist | 0.108 0.085 DBMET00387 | DBMET00387 | |
| 0.019 | 0.282 | 0.098 | NMDA receptor antagonist | 0.098 0.049 DBMET00387 | DBMET00387 | |
| 0.007 | 0.285 | 0.064 | NMDA 2 receptor antagonist | 0.064 0.058 DBMET00387 | DBMET00387 | |
| 0.023 | 0.342 | 0.108 | Acetylcholine M3 receptor agonist | 0.108 0.04 DBMET00387 | DBMET00387 | |
| 0.041 | 0.37 | 0.31 | HERG channel blocker | 0.31 0.047 DBMET00387 | DBMET00387 | |
| 0.082 | 0.453 | 0.259 | Sodium/bile acid cotransporter inhibitor | 0.259 0.119 DBMET01549 0.259 0.119 DBMET01550 | DBMET01550 | |
| 0.035 | 0.414 | 0.28 | Potassium channel (Voltage-sensitive) blocker | 0.28 0.056 DBMET00387 | DBMET00387 | |
| 0.005 | 0.4 | 0.029 | Potassium channel (Inward rectifier) 1 blocker | 0.029 0.025 DBMET00387 | DBMET00387 | |
| 0.008 | 0.404 | 0.105 | 5 Hydroxytryptamine 1F antagonist | 0.105 0.029 DBMET00387 | DBMET00387 | |
| 0.011 | 0.433 | 0.031 | DNA topoisomerase IV inhibitor | 0.031 0.018 DBMET00387 | DBMET00387 | |
| 0.02 | 0.451 | 0.103 | Acetylcholine muscarinic antagonist | 0.103 0.087 DBMET00387 | DBMET00387 | |
| 0.028 | 0.471 | 0.628 | Potassium channel blocker | 0.628 0.005 DBMET00387 | DBMET00387 | |
| 0.067 | 0.541 | 0.317 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.317 0.053 DBMET00387 | DBMET00387 | |
| 0.013 | 0.49 | 0.059 | DNA gyrase subunit A inhibitor | 0.059 0.01 DBMET00387 | DBMET00387 | |
| 0.009 | 0.498 | 0.049 | Protein kinase C eta inhibitor | 0.049 0.045 DBMET00387 | DBMET00387 | |
| 0.042 | 0.552 | 0.223 | Sigma receptor agonist | 0.223 0.055 DBMET00387 | DBMET00387 | |
| 0.019 | 0.579 | 0.124 | Acetylcholine M1 receptor antagonist | 0.124 0.102 DBMET00387 | DBMET00387 | |
| 0.01 | 0.586 | 0.116 | Topoisomerase II inhibitor | 0.116 0.071 DBMET00387 | DBMET00387 | |
| 0.006 | 0.655 | 0.081 | Alpha adrenoreceptor antagonist | 0.081 0.07 DBMET00387 | DBMET00387 | |
| 0.012 | 0.697 | 0.121 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.121 0.115 DBMET00387 | DBMET00387 | |
| 0.006 | 0.708 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.03 DBMET00387 | DBMET00387 | |
| 0.016 | 0.748 | 0.279 | Antibacterial | 0.279 0.152 DBMET00387 | DBMET00387 | |
| 0.003 | 0.768 | 0.157 | 5 Hydroxytryptamine 2C antagonist | 0.157 0.025 DBMET00387 | DBMET00387 | |
| 0.003 | 0.803 | 0.142 | 5 Hydroxytryptamine antagonist | 0.142 0.053 DBMET00387 | DBMET00387 | |
| 0.009 | 0.811 | 0.17 | Multidrug resistance-associated protein 1 inhibitor | 0.17 0.018 DBMET00387 | DBMET00387 | |
| 0.002 | 0.805 | 0.141 | 5 Hydroxytryptamine 2A antagonist | 0.141 0.031 DBMET00387 | DBMET00387 | |
| 0.003 | 0.811 | 0.21 | 5 Hydroxytryptamine 2 antagonist | 0.21 0.028 DBMET00387 | DBMET00387 | |
| 0.008 | 0.823 | 0.163 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.163 0.112 DBMET00387 | DBMET00387 | |
| 0.004 | 0.846 | 0.128 | 5 Hydroxytryptamine 2B antagonist | 0.128 0.053 DBMET00387 | DBMET00387 | |
| 0.003 | 0.889 | 0.101 | Insulin receptor antagonist | 0.101 0.06 DBMET00387 | DBMET00387 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |